217 related articles for article (PubMed ID: 32281166)
1. The potential of circulating microRNA-125a and microRNA-125b as markers for inflammation and clinical response to infliximab in rheumatoid arthritis patients.
Cheng P; Wang J
J Clin Lab Anal; 2020 Aug; 34(8):e23329. PubMed ID: 32281166
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA NEAT1 and its targets (microRNA-21 and microRNA-125a) in rheumatoid arthritis: Altered expression and potential to monitor disease activity and treatment outcome.
Yang J; Wang S; Liu L; Wang J; Shao Y
J Clin Lab Anal; 2021 Dec; 35(12):e24076. PubMed ID: 34708894
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-125b: association with disease activity and the treatment response of patients with early rheumatoid arthritis.
Hruskova V; Jandova R; Vernerova L; Mann H; Pecha O; Prajzlerova K; Pavelka K; Vencovsky J; Filkova M; Senolt L
Arthritis Res Ther; 2016 Jun; 18(1):124. PubMed ID: 27255643
[TBL] [Abstract][Full Text] [Related]
4. Plasma miR-125a and miR-125b in sepsis: Correlation with disease risk, inflammation, severity, and prognosis.
Zhao D; Li S; Cui J; Wang L; Ma X; Li Y
J Clin Lab Anal; 2020 Feb; 34(2):e23036. PubMed ID: 32077163
[TBL] [Abstract][Full Text] [Related]
5. Plasma Levels of MicroRNA-146a-5p, MicroRNA-24-3p, and MicroRNA-125a-5p as Potential Diagnostic Biomarkers for Rheumatoid Arthris.
Safari F; Damavandi E; Rostamian AR; Movassaghi S; Imani-Saber Z; Saffari M; Kabuli M; Ghadami M
Iran J Allergy Asthma Immunol; 2021 Jun; 20(3):326-337. PubMed ID: 34134454
[TBL] [Abstract][Full Text] [Related]
6. Serum Calprotectin Versus Acute-Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors.
Inciarte-Mundo J; Victoria Hernández M; Ruiz-Esquide V; Raquel Cabrera-Villalba S; Ramirez J; Cuervo A; Pascal M; Yagüe J; Cañete JD; Sanmarti R
Arthritis Care Res (Hoboken); 2016 Jul; 68(7):899-906. PubMed ID: 26841119
[TBL] [Abstract][Full Text] [Related]
7. Circulating miR-125a but not miR-125b is decreased in active disease status and negatively correlates with disease severity as well as inflammatory cytokines in patients with Crohn's disease.
Sun CM; Wu J; Zhang H; Shi G; Chen ZT
World J Gastroenterol; 2017 Nov; 23(44):7888-7898. PubMed ID: 29209130
[TBL] [Abstract][Full Text] [Related]
8. Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis.
Kizaki K; Yamashita F; Hayashi T; Funakoshi N
Int J Rheum Dis; 2018 Oct; 21(10):1815-1821. PubMed ID: 27778459
[TBL] [Abstract][Full Text] [Related]
9. Correlation of microRNA-125a/b with acute respiratory distress syndrome risk and prognosis in sepsis patients.
Li S; Zhao D; Cui J; Wang L; Ma X; Li Y
J Clin Lab Anal; 2020 Mar; 34(3):e23098. PubMed ID: 31967348
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNA-23b as a new biomarker for rheumatoid arthritis.
Liu X; Ni S; Li C; Xu N; Chen W; Wu M; van Wijnen AJ; Wang Y
Gene; 2019 Sep; 712():143911. PubMed ID: 31176730
[TBL] [Abstract][Full Text] [Related]
11. Time-course of health status in patients with rheumatoid arthritis during the first year of treatment with infliximab.
Ban A; Inaba M; Furumitsu Y; Okamoto K; Yukioka K; Goto H; Nishizawa Y
Biomed Pharmacother; 2010 Feb; 64(2):107-12. PubMed ID: 19944558
[TBL] [Abstract][Full Text] [Related]
12. Utility of Select Plasma MicroRNA for Disease and Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis.
Ormseth MJ; Solus JF; Vickers KC; Oeser AM; Raggi P; Stein CM
J Rheumatol; 2015 Oct; 42(10):1746-1751. PubMed ID: 26233505
[TBL] [Abstract][Full Text] [Related]
13. Circulating miRNA-125b is a potential biomarker predicting response to rituximab in rheumatoid arthritis.
Duroux-Richard I; Pers YM; Fabre S; Ammari M; Baeten D; Cartron G; Touitou I; Jorgensen C; Apparailly F
Mediators Inflamm; 2014; 2014():342524. PubMed ID: 24778468
[TBL] [Abstract][Full Text] [Related]
14. IL-6 is an independent predictive factor of drug survival after dose escalation of infliximab in patients with rheumatoid arthritis.
Takasugi K; Nishida K; Natsumeda M; Yamashita M; Yamamoto W; Ezawa K
Mod Rheumatol; 2018 May; 28(3):452-460. PubMed ID: 28828944
[TBL] [Abstract][Full Text] [Related]
15. Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center.
Takai C; Ito S; Kobayashi D; Nemoto T; Lee H; Abe A; Otani H; Nakazono K; Murasawa A; Ishikawa H
Intern Med; 2020; 59(16):1963-1970. PubMed ID: 32801270
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis.
Murata K; Furu M; Yoshitomi H; Ishikawa M; Shibuya H; Hashimoto M; Imura Y; Fujii T; Ito H; Mimori T; Matsuda S
PLoS One; 2013; 8(7):e69118. PubMed ID: 23874885
[TBL] [Abstract][Full Text] [Related]
17. Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
Nordal HH; Brun JG; Hordvik M; Eidsheim M; Jonsson R; Halse AK
Scand J Rheumatol; 2016 Jul; 45(4):274-81. PubMed ID: 26767827
[TBL] [Abstract][Full Text] [Related]
18. Derlin-1, as a Potential Early Predictive Biomarker for Nonresponse to Infliximab Treatment in Rheumatoid Arthritis, Is Related to Autophagy.
Cai Y; Xu K; Aihaiti Y; Li Z; Yuan Q; Xu J; Zheng H; Yang M; Wang B; Yang Y; Yang Y; Xu P
Front Immunol; 2021; 12():795912. PubMed ID: 35046954
[TBL] [Abstract][Full Text] [Related]
19. MiR-125b but not miR-125a is upregulated and exhibits a trend to correlate with enhanced disease severity, inflammation, and increased mortality in sepsis patients.
Zhu X
J Clin Lab Anal; 2020 Mar; 34(3):e23094. PubMed ID: 31696556
[TBL] [Abstract][Full Text] [Related]
20. Body mass index and response to infliximab in rheumatoid arthritis.
Ottaviani S; Gardette A; Tubach F; Roy C; Palazzo E; Gill G; Meyer O; Dieudé P
Clin Exp Rheumatol; 2015; 33(4):478-83. PubMed ID: 25962513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
